Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

Novartis' combo COPD inhaler cleared in EU

Novartis' combo COPD inhaler cleared in EU Advair (salmeterol and fluticasone) and AstraZeneca's $3bn Symbicort (formoterol and budesonide).

FDA guidance clears path for Advair generics

FDA guidance clears path for Advair generics The FDA's new draft guidance provides a simplified framework for companies trying to develop generics of Advair as well as other combination inhaled medicines such as AstraZeneca's Symbicort ... Moreover, it looks like the FDA will only require bridging

AstraZeneca boosts R&D prospects with Pearl acquisition

AstraZeneca boosts R&D prospects with Pearl acquisition AZ's CEO Soriot said the acquisition of Pearl complemented the company's current respiratory portfolio, which is currently dominated by Symbicort and Pulmicort, although both products are set to face

GSK submits COPD drug in US and EU

GSK submits COPD drug in US and EU approval for the use of Symbicort (budesonide/formoterol) in treating COPD.

GSK buoyed by FDA panel backing for Advair successor

GSK buoyed by FDA panel backing for Advair successor market. These include new market entrants, generics of AstraZeneca's Symbicort (budesonide/formoterol) which are already on the market, as well as patent expirations for Boehringer Ingelheim/Pfizer's big-selling

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics